rs771115907
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004064.5(CDKN1B):c.425C>A(p.Thr142Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000121 in 1,568,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T142T) has been classified as Likely benign.
Frequency
Consequence
NM_004064.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKN1B | NM_004064.5 | c.425C>A | p.Thr142Lys | missense_variant | 1/3 | ENST00000228872.9 | NP_004055.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKN1B | ENST00000228872.9 | c.425C>A | p.Thr142Lys | missense_variant | 1/3 | 1 | NM_004064.5 | ENSP00000228872.4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151326Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000409 AC: 1AN: 244494Hom.: 0 AF XY: 0.00000753 AC XY: 1AN XY: 132870
GnomAD4 exome AF: 0.0000120 AC: 17AN: 1417308Hom.: 0 Cov.: 38 AF XY: 0.0000156 AC XY: 11AN XY: 705846
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151326Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73914
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia type 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 26, 2023 | This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 142 of the CDKN1B protein (p.Thr142Lys). This variant is present in population databases (rs771115907, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with CDKN1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 824731). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The p.T142K variant (also known as c.425C>A), located in coding exon 1 of the CDKN1B gene, results from a C to A substitution at nucleotide position 425. The threonine at codon 142 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at